ME03430B - Jedinjenja amida kao agonisti 5-ht4 receptora - Google Patents
Jedinjenja amida kao agonisti 5-ht4 receptoraInfo
- Publication number
- ME03430B ME03430B MEP-2019-190A MEP2019190A ME03430B ME 03430 B ME03430 B ME 03430B ME P2019190 A MEP2019190 A ME P2019190A ME 03430 B ME03430 B ME 03430B
- Authority
- ME
- Montenegro
- Prior art keywords
- receptoragonists
- amide compounds
- amide
- compounds
- Prior art date
Links
- -1 AMIDE COMPOUNDS Chemical class 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN709CH2015 | 2015-02-13 | ||
| PCT/IN2016/000008 WO2016128990A1 (en) | 2015-02-13 | 2016-01-07 | Amide compounds as 5-ht4 receptor agonists |
| EP16711355.4A EP3265459B1 (en) | 2015-02-13 | 2016-01-07 | Amide compounds as 5-ht4 receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME03430B true ME03430B (me) | 2020-01-20 |
Family
ID=55588327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2019-190A ME03430B (me) | 2015-02-13 | 2016-01-07 | Jedinjenja amida kao agonisti 5-ht4 receptora |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US9957257B2 (me) |
| EP (1) | EP3265459B1 (me) |
| JP (1) | JP6487564B2 (me) |
| KR (1) | KR101966576B1 (me) |
| CN (1) | CN107406434B (me) |
| AU (1) | AU2016217461B2 (me) |
| BR (1) | BR112017017275A2 (me) |
| CA (1) | CA2975973C (me) |
| CY (1) | CY1121898T1 (me) |
| DK (1) | DK3265459T3 (me) |
| EA (1) | EA034618B1 (me) |
| ES (1) | ES2734734T3 (me) |
| HR (1) | HRP20191179T1 (me) |
| HU (1) | HUE045667T2 (me) |
| IL (1) | IL253848B (me) |
| LT (1) | LT3265459T (me) |
| MA (1) | MA41633B1 (me) |
| MD (1) | MD3265459T2 (me) |
| ME (1) | ME03430B (me) |
| MX (1) | MX368214B (me) |
| NZ (1) | NZ734400A (me) |
| PL (1) | PL3265459T3 (me) |
| PT (1) | PT3265459T (me) |
| RS (1) | RS59066B1 (me) |
| SG (1) | SG11201706501VA (me) |
| SI (1) | SI3265459T1 (me) |
| SM (1) | SMT201900398T1 (me) |
| TR (1) | TR201909997T4 (me) |
| WO (1) | WO2016128990A1 (me) |
| ZA (1) | ZA201705292B (me) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201402405QA (en) | 2011-11-18 | 2014-09-26 | Heptares Therapeutics Ltd | Muscarinic m1 receptor agonists |
| GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201519352D0 (en) | 2015-11-02 | 2015-12-16 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201709652D0 (en) * | 2017-06-16 | 2017-08-02 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819961D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| CN110818661B (zh) * | 2019-12-02 | 2021-08-06 | 上海再启生物技术有限公司 | 5-ht4受体激动剂的关键中间体4-氨基-5-卤苯并呋喃-7-羧酸的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2545092C (en) | 2003-11-24 | 2010-08-17 | Pfizer Inc. | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
| WO2005092882A1 (en) * | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders |
| CA2598516C (en) | 2005-02-25 | 2010-05-11 | Pfizer Inc. | Benzisoxazole derivatives |
| EP1910340B1 (en) | 2005-07-22 | 2009-11-18 | Pfizer, Inc. | Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| AR056729A1 (es) * | 2005-10-28 | 2007-10-17 | Glaxo Group Ltd | Compuesto de benzofurano carboxamida, composicion farmaceutica que lo comprende su uso para preparar un medicamento y procesos para su preparcion |
| GB0525661D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Novel compounds |
| GB0603550D0 (en) | 2006-02-22 | 2006-04-05 | Glaxo Group Ltd | Novel compounds |
| CA2789663C (en) * | 2010-02-12 | 2018-10-02 | Raqualia Pharma Inc. | 5-ht4 receptor agonists for the treatment of dementia |
| CA2788656A1 (en) | 2010-02-16 | 2011-08-25 | Pfizer Inc. | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
| AU2012311057B2 (en) | 2011-09-19 | 2015-09-17 | Suven Life Sciences Limited | Heteroaryl compounds as 5-HT4 receptor ligands |
| CA2907620C (en) * | 2013-03-20 | 2018-03-13 | Suven Life Sciences Limited | 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists |
| KR101824154B1 (ko) * | 2013-12-16 | 2018-03-14 | 수벤 라이프 사이언시스 리미티드 | 5-ｈｔ４ 수용체 작용제로서 인다졸 화합물 |
-
2016
- 2016-01-07 DK DK16711355.4T patent/DK3265459T3/da active
- 2016-01-07 ES ES16711355T patent/ES2734734T3/es active Active
- 2016-01-07 MD MDE20180052T patent/MD3265459T2/ro not_active IP Right Cessation
- 2016-01-07 MX MX2017010348A patent/MX368214B/es active IP Right Grant
- 2016-01-07 KR KR1020177025584A patent/KR101966576B1/ko not_active Expired - Fee Related
- 2016-01-07 HR HRP20191179TT patent/HRP20191179T1/hr unknown
- 2016-01-07 JP JP2017542107A patent/JP6487564B2/ja not_active Expired - Fee Related
- 2016-01-07 ME MEP-2019-190A patent/ME03430B/me unknown
- 2016-01-07 LT LTEP16711355.4T patent/LT3265459T/lt unknown
- 2016-01-07 WO PCT/IN2016/000008 patent/WO2016128990A1/en not_active Ceased
- 2016-01-07 CA CA2975973A patent/CA2975973C/en not_active Expired - Fee Related
- 2016-01-07 EA EA201791829A patent/EA034618B1/ru unknown
- 2016-01-07 CN CN201680015614.4A patent/CN107406434B/zh not_active Expired - Fee Related
- 2016-01-07 SI SI201630311T patent/SI3265459T1/sl unknown
- 2016-01-07 SG SG11201706501VA patent/SG11201706501VA/en unknown
- 2016-01-07 US US15/549,663 patent/US9957257B2/en active Active
- 2016-01-07 AU AU2016217461A patent/AU2016217461B2/en not_active Ceased
- 2016-01-07 EP EP16711355.4A patent/EP3265459B1/en active Active
- 2016-01-07 MA MA41633A patent/MA41633B1/fr unknown
- 2016-01-07 TR TR2019/09997T patent/TR201909997T4/tr unknown
- 2016-01-07 SM SM20190398T patent/SMT201900398T1/it unknown
- 2016-01-07 RS RS20190836A patent/RS59066B1/sr unknown
- 2016-01-07 HU HUE16711355A patent/HUE045667T2/hu unknown
- 2016-01-07 PL PL16711355T patent/PL3265459T3/pl unknown
- 2016-01-07 BR BR112017017275A patent/BR112017017275A2/pt not_active IP Right Cessation
- 2016-01-07 PT PT16711355T patent/PT3265459T/pt unknown
- 2016-01-07 NZ NZ734400A patent/NZ734400A/en not_active IP Right Cessation
-
2017
- 2017-08-04 ZA ZA2017/05292A patent/ZA201705292B/en unknown
- 2017-08-06 IL IL253848A patent/IL253848B/en active IP Right Grant
-
2019
- 2019-07-10 CY CY20191100739T patent/CY1121898T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4226898C0 (de) | Aktuator-dämpfer-einheit | |
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| PT3157915T (pt) | Compostos de dihidroisoquinolinona substituídos | |
| LT3134402T (lt) | 4-amino-imidazochinolino junginiai | |
| LT3197883T (lt) | Nauji junginiai | |
| CL2016002129A1 (es) | Compuestos de azolina | |
| PT3298027T (pt) | Compostos depsipéptidos antelmínticos | |
| ME03430B (me) | Jedinjenja amida kao agonisti 5-ht4 receptora | |
| DK3330593T3 (da) | Halo-lysenhed | |
| EP3334726A4 (en) | PINABULIN COMPOSITIONS | |
| SMT202200173T1 (it) | Composti | |
| CL2016002165A1 (es) | Compuestos de aminocarbonilcarbamato | |
| HUE054351T2 (hu) | Vegyületek | |
| DK3597189T3 (da) | Krystallinske forbindelser | |
| EP3309163A4 (en) | SUBSTITUTED DIHYDROPYRROLO PYRAZOL DERIVATIVE | |
| LT3183242T (lt) | Pakeistieji bicikliniai junginiai | |
| DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
| BR112018001062A2 (pt) | compostos inovadores | |
| EP3384016A4 (en) | MANIPULATED PHAGEMIDES | |
| HUE039805T2 (hu) | Új szulfonilaminobenzamid vegyületek | |
| EP3357916A4 (en) | benzamide | |
| DK3347403T3 (da) | Polyalkoxyfedtforbindelse | |
| DE102015206660A8 (de) | Plattenaufteilanlage | |
| EP3383846A4 (en) | Carbon monoxide releasing norbornenone compounds | |
| LT3331885T (lt) | Junginiai |